8/23/2013 - The State's Connecticut Innovations Commits $150,000 to ImStem Biotechnology of Farmington

2017-12-11 12:22:09

8/23/2013 - The State's Connecticut Innovations Commits $150,000 to ImStem Biotechnology of Farmington

“ImStem's work is not only important from a public health standpoint, but is part of a wider growing biotech industry that is creating well-paying, high-tech jobs,” said Mike Demicco (D-Farmington).

Connecticut Innovation, the state’s quasi-public authority responsible for growing businesses has committed funding totaling $150,000 through its Pre-Seed Fund to ImStem biotechnology startup venture.

ImStem Biotechnology Inc. is an emerging biotechnology company developing cell therapeutic products derived from human embryonic stem cells for use in tissue repair and treatment of neural, heart, vascular and blood system and autoimmune diseases.

 


Hengqin pins its future on attracting talent
2018/01/25

Hengqin pins its future on attracting talent

Hengqin pins its future on attracting ta..

6/05/2014-ImStem Biotechnology, Inc. Makes Progress on Multiple Sclerosis Treatment with Embryonic Stem Cells
2017/12/11

6/05/2014-ImStem Biotechnology, Inc. Makes Progress on Multiple Sclerosis Treatment with Embryonic Stem Cells

Farmington, Conn. - June 5, 2014. ImStem Biotechnology, Inc.(ImStem) announced t..

6/10/2013 -ImStem won 1.1 million stem cell research grant from State of Connecticut
2017/12/11

6/10/2013 -ImStem won 1.1 million stem cell research grant from State of Connecticut

IImStem won 1.1 million stem cell research grant from State of ConnecticutNine s..

2/18/2013 - New Stem Cell Company Opens Lab at UConn Health Center
2017/12/11

2/18/2013 - New Stem Cell Company Opens Lab at UConn Health Center

A new stem cell company, ImStem Biotechnology Inc., is the latest research ventu..

T-MSC granted the patent authorization of Japan and Australia
2018/01/25

T-MSC granted the patent authorization of Japan and Australia

T-MSC granted the patent authorization of Japan and AustraliaThe core technology..

9/12/2017-ImStem, UConn Obtain U.S. Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases
2017/12/11

9/12/2017-ImStem, UConn Obtain U.S. Patent for Mesenchymal Stem Cell Technology to Treat MS, Other Diseases

The U.S. Patent and Trademark Office has issued a patent for human embryonic ste..